Voltar
Editorial Revisado por pares
BIBTEX RIS

Ezetimibe: a new addition to lipid‐lowering therapy

2003; Wiley; Volume: 57; Issue: 8 Linguagem: Inglês

10.1111/j.1742-1241.2003.tb10582.x

ISSN

1742-1241

Autores

Anthony S. Wierzbicki,

Tópico(s)

Drug Transport and Resistance Mechanisms

Resumo

International Journal of Clinical PracticeVolume 57, Issue 8 p. 653-655 Editorial Ezetimibe: a new addition to lipid-lowering therapy AS Wierzbicki FACA, FACB, AS Wierzbicki FACA, FACB Department of Chemical Pathology St Thomas' Hospital, LondonSearch for more papers by this author AS Wierzbicki FACA, FACB, AS Wierzbicki FACA, FACB Department of Chemical Pathology St Thomas' Hospital, LondonSearch for more papers by this author First published: 01 October 2003 https://doi.org/10.1111/j.1742-1241.2003.tb10582.xCitations: 2Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article.Citing Literature Volume57, Issue8October 2003Pages 653-655 RelatedInformation

Referência(s)